Ingevity

Ingevity Corp. engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals and Performance Materials. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. Process purifications produce a number of activated carbon products for food, water, beverage and chemical purification applications. The Performance Chemicals segment primarily addresses applications in three product families: pavement technologies, oilfield technologies, and industrial specialties. The company was founded on March 27, 2015 and is headquartered in North Charleston, SC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Ingevity reports record revenue and EBITDA, eyes growth opportunities

Ingevity's strong financial performance in Q4 2022 and full year, coupled with sustainable growth initiatives and market opportunities, position the company for continued success. Despite challenges in customer destocking and COVID-19 impacts, Ingevity remains optimistic about future growth and margin improvements.

Ingevity reports solid Q1 performance amidst market challenges and opportunities

Ingevity's Q1 performance showed resilience amid market challenges, with a focus on diversification and innovation to drive growth.
While facing lowered guidance and cost pressures, the company remains optimistic about revenue and profitability increases through strategic initiatives.
Opportunities in Performance Materials, Advanced Polymers, and Pavement Technologies sectors position Ingevity for a positive outlook despite potential risks.

Ingevity reports strong Q2 growth, navigates challenges with strategic focus

Ingevity's Q2 2023 performance was marked by revenue growth, operational efficiency, and strategic agreements with Nexeon for silicon anode material.
Challenges from high CTO costs and weak end markets led to reduced guidance, but the company is focused on cost reduction and growth opportunities.
The AFA transition, global expansion in Pavement Technologies, and recovery plans for CTO costs highlight Ingevity's strategic initiatives for future growth.

Ingevity repositions for growth, faces challenges in Q3 performance

Ingevity's Q3 2023 performance reflected mixed results with notable strengths in Performance Materials and Advanced Polymer Technologies, while facing challenges in Performance Chemicals. The company's repositioning strategy and focus on higher-margin products present opportunities for improved profitability and growth. Despite lowered guidance for 2023, Ingevity remains committed to debt reduction and operational optimization.

Ingevity reports record Q4 sales, focuses on margin maintenance

Ingevity's Q4 performance highlighted record sales in key segments, offsetting challenges in others. The company remains focused on margin maintenance, new product adoption, and market opportunities. Despite facing volume declines and after-tax charges, Ingevity projects sales growth and adjusted EBITDA for 2024.

Ingevity reports mixed Q1 performance, optimistic on future growth

Ingevity's Q1 2024 earnings call highlighted mixed performance across segments, with strong growth in Performance Materials but challenges in APT and Performance Chemicals. The company reiterated full-year guidance and remains cautiously optimistic about future demand patterns and business transformation.

Ingevity reports Q3 sales decline, focuses on efficiency and portfolio

Ingevity's Q3 performance reflects short-term challenges from repositioning but also demonstrates operational resilience and strategic focus on efficiency and optimization.
The company's commitment to reviewing its business portfolio and pursuing improved execution and debt reduction signals a proactive approach to enhancing long-term value.
Analyst inquiries and guidance for Q4 underscore the importance of transparency, operational excellence, and strategic alignment in navigating market dynamics.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ingevity: Carbon Future At A Record Discount

While Ingevity (NGVT) is exposed to cost pressures, and weakness in industrial specialties and oilfield applications, it should gain from the Capa acquisition.

Ingevity to Gain From Capa Buyout & Regulation-driven Demand

Let's find out why specialty chemicals and materials maker Ingevity (NGVT) is worth retaining at the moment.

Here's Why You Should Hold Onto Ingevity (NGVT) Stock Now

Ingevity's (NGVT) first quarter is going better than anticipated despite modest headwinds from the coronavirus outbreak.

Ingevity Provides Update in Response to Coronavirus Outbreak

Ashland Global Hlds

Axalta Coating Systems

Celanese

Daqo New Energy

Ecolab

W. R. Grace & Co.

Coronavirus, Tariffs Mar Chemical Specialty Industry Outlook

Ingevity Corporation (NGVT) reported earnings 30 days ago. What's next for the stock?

Why Is Ingevity Corporation (NGVT) Down 23.9% Since Last Earnings Report?

Ingevity's (NGVT) new authorization provides it with the flexibility to be opportunistic through 2020.

Ingevity (NGVT) Authorizes Share Repurchase Worth $500M

Ingevity Corp. NGVT, -3.44% announced Thursday afternoon that its chief executive resigned as "the result of matters relating to his personal conduct.

Ingevity CEO steps down because of 'personal conduct'

While Ingevity (NGVT) faced challenges from continued macroeconomic pressure in the fourth quarter, it gained from growth in end-use applications.

Ingevity (NGVT) Q4 Earnings Surpass Estimates, Sales Miss

Ingevity Corp (NGVT) CEO Michael Wilson on Q4 2019 Results - Earnings Call Transcript

Ingevity Corporation (NGVT) delivered earnings and revenue surprises of 12.24% and -0.24%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Ingevity Corporation (NGVT) Q4 Earnings Beat Estimates

Ingevity Corporation (NGVT) Up 2.7% Since Last Earnings Report: Can It Continue?

Near-Term Prospects Gloomy for Specialty Chemical Stocks

Ingevity's (NGVT) CEO Michael Wilson on Q3 2019 Results - Earnings Call Transcript

While Ingevity (NGVT) faced challenges from weak market conditions in Q3, it gained from the Capa caprolactone acquisition.

Ingevity's (NGVT) Earnings Top Estimates in Q3, Sales Miss

Ingevity Corporation (NGVT) delivered earnings and revenue surprises of 2.82% and -1.47%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Ingevity Corporation (NGVT) Q3 Earnings Beat Estimates

On Wednesday, Ingevity (NYSE: NGVT) will release its latest earnings report. Decipher the announcement with Benzinga's help.

Q3 Earnings Outlook For Ingevity

Ingevity Corporation (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ingevity Corporation (NGVT) Reports Next Week: Wall Street Expects Earnings Growth

AXTA vs. NGVT: Which Stock Is the Better Value Option?

AXTA vs. NGVT: Which Stock Should Value Investors Buy Now?

Ingevity Corporation (NGVT) Down 20.7% Since Last Earnings Report: Can It Rebound?

ICL-Israel Chemicals

ICL vs. NGVT: Which Stock Is the Better Value Option?

ICL or NGVT: Which Is the Better Value Stock Right Now?

Ingevity Corporation (NGVT) CEO Michael Wilson on Q2 2019 Results - Earnings Call Transcript

Ingevity (NGVT) gains from inorganic and organic growth strategy in Q2. The company reaffirms guidance for 2019.

Ingevity's (NGVT) Earnings Beat Estimates in Q2, Sales Lag

Ingevity Corporation (NGVT) delivered earnings and revenue surprises of 0.74% and -3.52%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

News for Ingevity Stock (NGVT)